Abstract
Non-steroidal anti-inflammatory drugs (NSAIDs) are a group of often chemically unrelated compounds with some common therapeutic actions and side effects. They have potent anti-inflammatory, analgesic and antipyretic activity, and are among the most widely used drugs worldwide. It is generally thought that one of their main mechanisms of action is the inhibition of cyclo-oxygenase (COX), the enzyme responsible for biosynthesing the prostaglandins and thromboxane. NSAIDs are also associated with an increased risk of adverse gastrointestinal, renal and cardiovascular effects. This review describes the clinical pharmacology of NSAIDs, their classification, molecular mechanisms of action and adverse effects, including their possible contribution to neuro-inflammation and carcinogenesis, as well as some recent developments aimed at designing effective anti-inflammatory agents with improved safety and tolerability profiles.
Keywords: NSAIDs, cyclo-oxygenases, prostanoids, adverse effects, cancer, neuro-inflammation, safe NSAIDs, Non-Steroidal Anti-Inflammatory Drugs, selective COX-2 inhibitors , COXIBs, COX-1 , COX-2 , enzyme catalysis , cytoprotection, Hydrogen sulfide-releasing non-steroidal anti-inflammatory, Nitric oxide-releasing non-steroidal anti-inflammatory
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title:Clinical Pharmacology of Non-Steroidal Anti-Inflammatory Drugs: A Review
Volume: 11 Issue: 1
Author(s): S. Bacchi, P. Palumbo, A. Sponta and M.F. Coppolino
Affiliation:
Keywords: NSAIDs, cyclo-oxygenases, prostanoids, adverse effects, cancer, neuro-inflammation, safe NSAIDs, Non-Steroidal Anti-Inflammatory Drugs, selective COX-2 inhibitors , COXIBs, COX-1 , COX-2 , enzyme catalysis , cytoprotection, Hydrogen sulfide-releasing non-steroidal anti-inflammatory, Nitric oxide-releasing non-steroidal anti-inflammatory
Abstract: Non-steroidal anti-inflammatory drugs (NSAIDs) are a group of often chemically unrelated compounds with some common therapeutic actions and side effects. They have potent anti-inflammatory, analgesic and antipyretic activity, and are among the most widely used drugs worldwide. It is generally thought that one of their main mechanisms of action is the inhibition of cyclo-oxygenase (COX), the enzyme responsible for biosynthesing the prostaglandins and thromboxane. NSAIDs are also associated with an increased risk of adverse gastrointestinal, renal and cardiovascular effects. This review describes the clinical pharmacology of NSAIDs, their classification, molecular mechanisms of action and adverse effects, including their possible contribution to neuro-inflammation and carcinogenesis, as well as some recent developments aimed at designing effective anti-inflammatory agents with improved safety and tolerability profiles.
Export Options
About this article
Cite this article as:
Bacchi S., Palumbo P., Sponta A. and Coppolino M.F., Clinical Pharmacology of Non-Steroidal Anti-Inflammatory Drugs: A Review, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2012; 11 (1) . https://dx.doi.org/10.2174/187152312803476255
DOI https://dx.doi.org/10.2174/187152312803476255 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Diabetic CVD – Soluble Epoxide Hydrolase as A Target
Cardiovascular & Hematological Agents in Medicinal Chemistry Platelet Toll-Like Receptor Expression: The Link Between “Danger” Ligands and Inflammation
Inflammation & Allergy - Drug Targets (Discontinued) Craniofacial Fibrous Dysplasia Involvements of Mccune-Albright Syndrome: A Review with an Additional Case
Current Medical Imaging Inflammation in Coronary Artery Disease and Acute Myocardial Infarction - is the Stage Set for Novel Therapies?
Current Pharmaceutical Design Use of Paediatric Xylometazoline Nasal Drop is not a Child’s Play in Hypertensive Patients on Bisoprolol: A Case Report
Current Drug Safety Patent Selections:
Recent Patents on Medical Imaging Relationships Between Alcohol Consumption, Smoking Status and Food Habits in Greek Adolescents. Vascular Implications for the Future
Current Vascular Pharmacology Randomized Clinical Stroke Trials in 2006
Current Vascular Pharmacology Targeting Cancer Stem Cells with Natural Products
Current Drug Targets Effect of Cardioembolic Etiology on Intravenous Thrombolysis Efficacy for Acute Ischemic Stroke
Current Neurovascular Research Lipoprotein (a) and Cardiovascular Risk: The Show Must go on
Current Medicinal Chemistry Common and Less Common Peripheral Nerve Disorders Associated with Diabetes
Current Diabetes Reviews An update on the Management and Treatment of Deep Vein Thrombosis
Cardiovascular & Hematological Agents in Medicinal Chemistry MCP-1/CCL2 as a Therapeutic Target in Myocardial Infarction and Ischemic Cardiomyopathy
Inflammation & Allergy - Drug Targets (Discontinued) Pharmacological Neuroprotection in Stroke: Rationale, State-of-the-art and Future Directions
Current Neuropharmacology Proteomic Analysis of Liver Preservation Solutions Prior to Liver Transplantation
Current Proteomics Clinical Applications of Transcranial Doppler Sonography
Reviews on Recent Clinical Trials Blood-Brain-Barrier Models for the Investigation of Transporter- and Receptor-Mediated Amyloid-β Clearance in Alzheimers Disease
Current Alzheimer Research Modification of Decoy Oligodeoxynucleotides to Achieve the Stability and Therapeutic Efficacy
Current Topics in Medicinal Chemistry Radiologic Findings of IgG4-Related Disease
Current Immunology Reviews (Discontinued)